nitisinone has been researched along with amlexanox in 1 studies
| Studies (nitisinone) | Trials (nitisinone) | Recent Studies (post-2010) (nitisinone) | Studies (amlexanox) | Trials (amlexanox) | Recent Studies (post-2010) (amlexanox) |
|---|---|---|---|---|---|
| 242 | 12 | 150 | 138 | 16 | 74 |
| Protein | Taxonomy | nitisinone (IC50) | amlexanox (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.2 | |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | 5.1143 | |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 0.8506 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kashihara, M; Mizuguchi, M; Yokoyama, T | 1 |
1 other study(ies) available for nitisinone and amlexanox
| Article | Year |
|---|---|
Repositioning of the Anthelmintic Drugs Bithionol and Triclabendazole as Transthyretin Amyloidogenesis Inhibitors.
Topics: Amyloid Neuropathies, Familial; Anthelmintics; Bithionol; Crystallography, X-Ray; Drug Repositioning; Humans; Prealbumin; Thermodynamics; Triclabendazole | 2021 |